K-Ras-ERK1/2 accelerates lung cancer cell development via mediating H3^K18ac through the MDM2-GCN5-SIRT7 axis

References

• Baietti MF, Simicek M, Abbasi Asbagh L, Radaelli E, Lievens S, Crowther J, Steklov M, Aushev VN, Martinez Garcia D, Tavernier J, et al. 2016. OTUB1 triggers lung cancer development by inhibiting RAS monoubiquitination. EMBO Mol Med. 8(3):288–303.
   PubMed Web of Science ®Google Scholar
• Barber MF, Michishita-Kioi E, Xi Y, Tasselli L, Kioi M, Moqtaderi Z, Tennen RI, Paredes S, Young NL, Chen K, et al. 2012. SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature. 487(7405):114–118.
   PubMed Web of Science ®Google Scholar
• Burgess SM, Ajimura M, Kleckner N. 1999. GCN5-dependent histone H3 acetylation and RPD3-dependent histone H4 deacetylation have distinct, opposing effects on IME2 transcription, during meiosis and during vegetative growth, in budding yeast. Proc Natl Acad Sci USA. 96(12):6835–6840.
   PubMed Web of Science ®Google Scholar
• Bustin SA. 2002. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol. 29(1):23–39.
   PubMed Web of Science ®Google Scholar
• Chaffer CL, Weinberg RA. 2011. A perspective on cancer cell metastasis. Science. 331(6024):1559–1564.
   PubMed Web of Science ®Google Scholar
• Cheng D, Zhao L, Xu Y, Ou R, Li G, Yang H, Li W. 2015. K-Ras promotes the non-small lung cancer cells survival by cooperating with sirtuin 1 and p27 under ROS stimulation. Tumour Biol. 36(9):7221–7232.
   PubMedGoogle Scholar
• Cieniewicz AM, Moreland L, Ringel AE, Mackintosh SG, Raman A, Gilbert TM, Wolberger C, Tackett AJ, Taverna SD. 2014. The bromodomain of Gcn5 regulates site specificity of lysine acetylation on histone H3. Mol Cell Proteomics. 13(11):2896–2910.
   PubMed Web of Science ®Google Scholar
• Cooper JM, Bodemann BO, White MA. 2013. The RalGEF/Ral pathway: evaluating an intervention opportunity for Ras cancers. Enzymes. 34:137–156.
   PubMedGoogle Scholar
• Del Vescovo V, Denti MA. 2015. microRNA and lung cancer. Adv Exp Med Biol. 889:153–177.
   PubMed Web of Science ®Google Scholar
• Goel S, Huang J, Klampfer L. 2015. K-Ras, intestinal homeostasis and colon cancer. Curr Clin Pharmacol. 10(1):73–81.
   PubMed Web of Science ®Google Scholar
• Guo L, Costanzo-Garvey DL, Smith DR, Zavorka ME, Venable-Kang M, MacDonald RG, Lewis RE. 2016. Cell non-autonomous regulation of hepatic IGF-1 and neonatal growth by Kinase Suppressor of Ras 2 (KSR2). Sci Rep. 6:32093.
   PubMed Web of Science ®Google Scholar
• Harada H, Omi M, Sato T, Nakamura H. 2015. Pea3 determines the isthmus region at the downstream of Fgf8-Ras-ERK signaling pathway. Dev Growth Differ. 57(9):657–666.
   PubMed Web of Science ®Google Scholar
• Hattori N, Ushijima T. 2014. Compendium of aberrant DNA methylation and histone modifications in cancer. Biochem Biophys Res Commun. 455(1–2):3–9.
   PubMed Web of Science ®Google Scholar
• Hensing T, Chawla A, Batra R, Salgia R. 2014. A personalized treatment for lung cancer: molecular pathways, targeted therapies, and genomic characterization. Adv Exp Med Biol. 799:85–117.
   PubMed Web of Science ®Google Scholar
• Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ, Jr., Wu YL, Paz-Ares L. 2017. Lung cancer: current therapies and new targeted treatments. Lancet. 389(10066):299–311.
   PubMed Web of Science ®Google Scholar
• Horibata S, Vo TV, Subramanian V, Thompson PR, Coonrod SA. 2015. Utilization of the soft agar colony formation assay to identify inhibitors of tumorigenicity in breast cancer cells. J Vis Exp. 20:e52727.
   Google Scholar
• Hussain S. 2016. Nanomedicine for treatment of lung cancer. Adv Exp Med Biol. 890:137–147.
   PubMed Web of Science ®Google Scholar
• Jiang W, Wei K, Pan C, Li H, Cao J, Han X, Tang Y, Zhu S, Yuan W, He Y, et al. 2018. MicroRNA-1258 suppresses tumour progression via GRB2/Ras/Erk pathway in non-small-cell lung cancer. Cell Prolif. 51(6):e12502.
   PubMed Web of Science ®Google Scholar
• Jiao F, Hu H, Yuan C, Jin Z, Guo Z, Wang L, Wang L. 2014. Histone deacetylase 3 promotes pancreatic cancer cell proliferation, invasion and increases drug-resistance through histone modification of P27, P53 and Bax. Int J Oncol. 45(4):1523–1530.
   PubMed Web of Science ®Google Scholar
• Johnson LM, Price DK, Figg WD. 2013. Treatment-induced secretion of WNT16B promotes tumor growth and acquired resistance to chemotherapy: implications for potential use of inhibitors in cancer treatment. Cancer Biol Ther. 14(2):90–91.
   PubMed Web of Science ®Google Scholar
• Karasawa T, Kawashima A, Usui F, Kimura H, Shirasuna K, Inoue Y, Komada T, Kobayashi M, Mizushina Y, Sagara J, et al. 2015. Oligomerized CARD16 promotes caspase-1 assembly and IL-1β processing. FEBS Open Bio. 5:348–356.
   PubMed Web of Science ®Google Scholar
• Lawrence M, Daujat S, Schneider R. 2016. Lateral thinking: how histone modifications regulate gene expression. Trends Genet. 32(1):42–56.
   PubMed Web of Science ®Google Scholar
• Li C, Wang J, Kong J, Tang J, Wu Y, Xu E, Zhang H, Lai M. 2016. GDF15 promotes EMT and metastasis in colorectal cancer. Oncotarget. 7(1):860–872.
   PubMedGoogle Scholar
• Li Y, Jaramillo-Lambert AN, Yang Y, Williams R, Lee NH, Zhu W. 2012. And-1 is required for the stability of histone acetyltransferase Gcn5. Oncogene. 31(5):643–652.
   PubMed Web of Science ®Google Scholar
• Lippman Z, Gendrel AV, Colot V, Martienssen R. 2005. Profiling DNA methylation patterns using genomic tiling microarrays. Nat Methods. 2(3):219–224.
   PubMed Web of Science ®Google Scholar
• Ma L, Yuan L, An J, Barton MC, Zhang Q, Liu Z. 2016. Histone H3 lysine 23 acetylation is associated with oncogene TRIM24 expression and a poor prognosis in breast cancer. Tumour Biol. 37(11):14803–14812.
   PubMedGoogle Scholar
• Martinez-Redondo P, Santos-Barriopedro I, Vaquero A. 2012. A big step for SIRT7, one giant leap for Sirtuins… in cancer. Cancer Cell. 21(6):719–721.
   PubMed Web of Science ®Google Scholar
• Minsky N, Oren M. 2004. The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression. Mol Cell. 16(4):631–639.
   PubMed Web of Science ®Google Scholar
• Nihira NT, Ogura K, Shimizu K, North BJ, Zhang J, Gao D, Inuzuka H, Wei W. 2017. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function. Sci Signal. 10(466):eaai8026.
   PubMed Web of Science ®Google Scholar
• Niu Z, Zheng L, Wu S, Mu H, Ma F, Song W, Zhu H, Wu J, He X, Hua J. 2015. Ras/ERK1/2 pathway regulates the self-renewal of dairy goat spermatogonia stem cells. Reproduction. 149(5):445–452.
   PubMed Web of Science ®Google Scholar
• Rodrigues LM, Uribe-Lewis S, Madhu B, Honess DJ, Stubbs M, Griffiths JR. 2017. The action of β-hydroxybutyrate on the growth, metabolism and global histone H3 acetylation of spontaneous mouse mammary tumours: evidence of a β-hydroxybutyrate paradox. Cancer Metab. 5:4.
   PubMed Web of Science ®Google Scholar
• Rui Y, Wang C, Zhou Z, Zhong X, Yu Y. 2015. K-Ras mutation and prognosis of colorectal cancer: a meta-analysis. Hepato-gastroenterology. 62(137):19–24.
   PubMedGoogle Scholar
• Samatar AA, Poulikakos PI. 2014. Targeting RAS-ERK signalling in cancer: promises and challenges. Nat Rev Drug Discov. 13(12):928–942.
   PubMed Web of Science ®Google Scholar
• Schulz S, Haussler S. 2014. Chromatin immunoprecipitation for ChIP-chip and ChIP-seq. Methods Mol Biol. 1149:591–605.
   PubMedGoogle Scholar
• Semenova EA, Nagel R, Berns A. 2015. Origins, genetic landscape, and emerging therapies of small cell lung cancer. Genes Dev. 29(14):1447–1462.
   PubMed Web of Science ®Google Scholar
• Shim Y, Duan MR, Chen X, Smerdon MJ, Min JH. 2012. Polycistronic coexpression and nondenaturing purification of histone octamers. Anal Biochem. 427(2):190–192.
   PubMed Web of Science ®Google Scholar
• Sundar IK, Rahman I. 2016. Gene expression profiling of epigenetic chromatin modification enzymes and histone marks by cigarette smoke: implications for COPD and lung cancer. Am J Physiol Lung Cell Mol Physiol. 311:1245–1258.
   PubMed Web of Science ®Google Scholar
• Tasselli L, Xi Y, Zheng W, Tennen RI, Odrowaz Z, Simeoni F, Li W, Chua KF. 2016. SIRT6 deacetylates H3K18ac at pericentric chromatin to prevent mitotic errors and cellular senescence. Nat Struct Mol Biol. 23(5):434–440.
   PubMed Web of Science ®Google Scholar
• Vicent S, López-Picazo JM, Toledo G, Lozano MD, Torre W, Garcia-Corchón C, Quero C, Soria J-C, Martín-Algarra S, Manzano RG, Montuenga LM. 2004. ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours. Br J Cancer. 90(5):1047–1052.
   PubMed Web of Science ®Google Scholar
• Voisset E, Oeztuerk-Winder F, Ruiz EJ, Ventura JJ. 2013. p38α Negatively regulates survival and malignant selection of transformed bronchioalveolar stem cells. PloS One. 8(11):e78911.
   PubMed Web of Science ®Google Scholar
• Wang HL, Lu RQ, Xie SH, Zheng H, Wen XM, Gao X, Guo L. 2015. SIRT7 exhibits oncogenic potential in human ovarian cancer cells. Asian Pac J Cancer Prev. 16(8):3573–3577.
   PubMedGoogle Scholar
• Wang N, Xiang X, Chen K, Liu P, Zhu A. 2018. Targeting of NT5E by miR-30b and miR-340 attenuates proliferation, invasion and migration of gallbladder carcinoma. Biochimie. 146:56–67.
   PubMed Web of Science ®Google Scholar
• Xu W, Chou CL, Israel DD, Hutchinson AJ, Regan JW. 2009. PGF(2alpha) stimulates FP prostanoid receptor mediated crosstalk between Ras/Raf signaling and Tcf transcriptional activation. Biochem Biophys Res Commun. 381(4):625–629.
   PubMed Web of Science ®Google Scholar
• Yang HW, Shin MG, Lee S, Kim JR, Park WS, Cho KH, Meyer T, Heo WD. 2012. Cooperative activation of PI3K by Ras and Rho family small GTPases. Mol Cell. 47(2):281–290.
   PubMed Web of Science ®Google Scholar
• Zhang S, Chen P, Huang Z, Hu X, Chen M, Hu S, Hu Y, Cai T. 2015. Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a. Sci Rep. 5:9787.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang Q, Wang S. 2014. MicroRNAs: a new key in lung cancer. Cancer Chemother Pharmacol. 74(6):1105–1111.
   PubMed Web of Science ®Google Scholar
• Zhao YY, Yu L, Liu BL, He XJ, Zhang BY. 2015. Downregulation of P-gp, Ras and p-ERK1/2 contributes to the arsenic trioxide-induced reduction in drug resistance towards doxorubicin in gastric cancer cell lines. Mol Med Rep. 12(5):7335–7343.
   PubMed Web of Science ®Google Scholar